nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Estrone—prostate cancer	0.344	0.794	CrCtD
Testolactone—CYP19A1—prostate cancer	0.187	1	CbGaD
Testolactone—Prednisone—prostate cancer	0.0895	0.206	CrCtD
Testolactone—Testosterone—Abiraterone—prostate cancer	0.0273	0.09	CrCrCtD
Testolactone—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.026	0.0859	CrCrCtD
Testolactone—Estrone—Estramustine—prostate cancer	0.0221	0.0731	CrCrCtD
Testolactone—Exemestane—Estrone—prostate cancer	0.0221	0.0731	CrCrCtD
Testolactone—Exemestane—Conjugated Estrogens—prostate cancer	0.0195	0.0643	CrCrCtD
Testolactone—Formestane—Estrone—prostate cancer	0.0185	0.0611	CrCrCtD
Testolactone—Formestane—Conjugated Estrogens—prostate cancer	0.0163	0.0538	CrCrCtD
Testolactone—Estrone—Conjugated Estrogens—prostate cancer	0.0155	0.0511	CrCrCtD
Testolactone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0153	0.0506	CrCrCtD
Testolactone—Estrone—Estradiol—prostate cancer	0.0133	0.044	CrCrCtD
Testolactone—Estrone—Ethinyl Estradiol—prostate cancer	0.013	0.0429	CrCrCtD
Testolactone—Testosterone—Estramustine—prostate cancer	0.0113	0.0374	CrCrCtD
Testolactone—Danazol—Ethinyl Estradiol—prostate cancer	0.0105	0.0345	CrCrCtD
Testolactone—Testosterone—Estrone—prostate cancer	0.00899	0.0297	CrCrCtD
Testolactone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.00747	0.0247	CrCrCtD
Testolactone—Testosterone—Estradiol—prostate cancer	0.00681	0.0225	CrCrCtD
Testolactone—Exemestane—Prednisone—prostate cancer	0.00575	0.019	CrCrCtD
Testolactone—Ciclesonide—Prednisone—prostate cancer	0.00382	0.0126	CrCrCtD
Testolactone—Danazol—Prednisone—prostate cancer	0.00367	0.0121	CrCrCtD
Testolactone—Prednicarbate—Prednisone—prostate cancer	0.00301	0.00992	CrCrCtD
Testolactone—Budesonide—Prednisone—prostate cancer	0.00276	0.00912	CrCrCtD
Testolactone—CYP19A1—semen—prostate cancer	0.00272	0.694	CbGeAlD
Testolactone—Desonide—Prednisone—prostate cancer	0.00269	0.00888	CrCrCtD
Testolactone—Methyltestosterone—Prednisone—prostate cancer	0.00262	0.00866	CrCrCtD
Testolactone—Desoximetasone—Prednisone—prostate cancer	0.00256	0.00845	CrCrCtD
Testolactone—Triamcinolone—Prednisone—prostate cancer	0.0025	0.00825	CrCrCtD
Testolactone—Mometasone—Prednisone—prostate cancer	0.0025	0.00825	CrCrCtD
Testolactone—Fluprednidene Acetate—Prednisone—prostate cancer	0.0025	0.00825	CrCrCtD
Testolactone—Loteprednol—Prednisone—prostate cancer	0.0025	0.00825	CrCrCtD
Testolactone—Betamethasone—Prednisone—prostate cancer	0.00244	0.00806	CrCrCtD
Testolactone—Dexamethasone—Prednisone—prostate cancer	0.00244	0.00806	CrCrCtD
Testolactone—Rimexolone—Prednisone—prostate cancer	0.00244	0.00806	CrCrCtD
Testolactone—Methylprednisolone—Prednisone—prostate cancer	0.00234	0.00771	CrCrCtD
Testolactone—Prednisolone—Prednisone—prostate cancer	0.00229	0.00755	CrCrCtD
Testolactone—Blood pressure increased—Estrone—prostate cancer	0.000979	0.0264	CcSEcCtD
Testolactone—Blood pressure increased—Estradiol valerate/Dienogest—prostate cancer	0.000855	0.0231	CcSEcCtD
Testolactone—Ache—Estradiol—prostate cancer	0.000784	0.0212	CcSEcCtD
Testolactone—CYP19A1—prostate gland—prostate cancer	0.000682	0.174	CbGeAlD
Testolactone—Blood pressure increased—Ethinyl Estradiol—prostate cancer	0.000555	0.015	CcSEcCtD
Testolactone—Alopecia—Estramustine—prostate cancer	0.000455	0.0123	CcSEcCtD
Testolactone—Blood pressure increased—Conjugated Estrogens—prostate cancer	0.000453	0.0122	CcSEcCtD
Testolactone—Alopecia—Nilutamide—prostate cancer	0.000404	0.0109	CcSEcCtD
Testolactone—Erythema—Flutamide—prostate cancer	0.000396	0.0107	CcSEcCtD
Testolactone—Ill-defined disorder—Nilutamide—prostate cancer	0.000369	0.00996	CcSEcCtD
Testolactone—Ill-defined disorder—Flutamide—prostate cancer	0.000367	0.00991	CcSEcCtD
Testolactone—Discomfort—Abiraterone—prostate cancer	0.000366	0.00988	CcSEcCtD
Testolactone—Oedema—Estramustine—prostate cancer	0.000366	0.00987	CcSEcCtD
Testolactone—Blood pressure increased—Estradiol—prostate cancer	0.000362	0.00977	CcSEcCtD
Testolactone—Alopecia—Degarelix—prostate cancer	0.000361	0.00973	CcSEcCtD
Testolactone—Malaise—Nilutamide—prostate cancer	0.000359	0.00968	CcSEcCtD
Testolactone—Malaise—Flutamide—prostate cancer	0.000357	0.00964	CcSEcCtD
Testolactone—Oedema—Abiraterone—prostate cancer	0.000355	0.00959	CcSEcCtD
Testolactone—Erythema—Degarelix—prostate cancer	0.000355	0.00959	CcSEcCtD
Testolactone—Oedema—Estrone—prostate cancer	0.000349	0.00943	CcSEcCtD
Testolactone—Anorexia—Estramustine—prostate cancer	0.000349	0.00941	CcSEcCtD
Testolactone—Alopecia—Cabazitaxel—prostate cancer	0.00034	0.00917	CcSEcCtD
Testolactone—Erythema—Cabazitaxel—prostate cancer	0.000335	0.00903	CcSEcCtD
Testolactone—Discomfort—Nilutamide—prostate cancer	0.000335	0.00903	CcSEcCtD
Testolactone—Discomfort—Flutamide—prostate cancer	0.000333	0.00899	CcSEcCtD
Testolactone—Ill-defined disorder—Degarelix—prostate cancer	0.00033	0.0089	CcSEcCtD
Testolactone—Oedema—Nilutamide—prostate cancer	0.000325	0.00876	CcSEcCtD
Testolactone—Oedema—Flutamide—prostate cancer	0.000323	0.00872	CcSEcCtD
Testolactone—Malaise—Degarelix—prostate cancer	0.00032	0.00865	CcSEcCtD
Testolactone—Decreased appetite—Estramustine—prostate cancer	0.000318	0.00858	CcSEcCtD
Testolactone—Ill-defined disorder—Cabazitaxel—prostate cancer	0.000311	0.00838	CcSEcCtD
Testolactone—Anorexia—Nilutamide—prostate cancer	0.000309	0.00835	CcSEcCtD
Testolactone—Anorexia—Flutamide—prostate cancer	0.000308	0.00831	CcSEcCtD
Testolactone—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.000305	0.00823	CcSEcCtD
Testolactone—Malaise—Cabazitaxel—prostate cancer	0.000302	0.00814	CcSEcCtD
Testolactone—CYP19A1—testis—prostate cancer	0.0003	0.0766	CbGeAlD
Testolactone—Discomfort—Degarelix—prostate cancer	0.000299	0.00806	CcSEcCtD
Testolactone—Pain—Estrone—prostate cancer	0.000299	0.00806	CcSEcCtD
Testolactone—Paraesthesia—Nilutamide—prostate cancer	0.000291	0.00787	CcSEcCtD
Testolactone—Alopecia—Bicalutamide—prostate cancer	0.000291	0.00786	CcSEcCtD
Testolactone—Decreased appetite—Nilutamide—prostate cancer	0.000282	0.00761	CcSEcCtD
Testolactone—Discomfort—Cabazitaxel—prostate cancer	0.000282	0.0076	CcSEcCtD
Testolactone—Decreased appetite—Flutamide—prostate cancer	0.000281	0.00758	CcSEcCtD
Testolactone—Pain—Nilutamide—prostate cancer	0.000278	0.00749	CcSEcCtD
Testolactone—Oedema—Cabazitaxel—prostate cancer	0.000273	0.00737	CcSEcCtD
Testolactone—Feeling abnormal—Nilutamide—prostate cancer	0.000267	0.00722	CcSEcCtD
Testolactone—Feeling abnormal—Flutamide—prostate cancer	0.000266	0.00719	CcSEcCtD
Testolactone—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000261	0.00704	CcSEcCtD
Testolactone—Anorexia—Cabazitaxel—prostate cancer	0.00026	0.00703	CcSEcCtD
Testolactone—Decreased appetite—Degarelix—prostate cancer	0.000252	0.0068	CcSEcCtD
Testolactone—Pain—Degarelix—prostate cancer	0.000248	0.00669	CcSEcCtD
Testolactone—Alopecia—Ethinyl Estradiol—prostate cancer	0.000246	0.00665	CcSEcCtD
Testolactone—Paraesthesia—Cabazitaxel—prostate cancer	0.000245	0.00662	CcSEcCtD
Testolactone—Feeling abnormal—Degarelix—prostate cancer	0.000239	0.00645	CcSEcCtD
Testolactone—Decreased appetite—Cabazitaxel—prostate cancer	0.000237	0.00641	CcSEcCtD
Testolactone—Oedema—Bicalutamide—prostate cancer	0.000234	0.00632	CcSEcCtD
Testolactone—Pain—Cabazitaxel—prostate cancer	0.000234	0.0063	CcSEcCtD
Testolactone—Blood pressure increased—Docetaxel—prostate cancer	0.000233	0.0063	CcSEcCtD
Testolactone—Vomiting—Estramustine—prostate cancer	0.000233	0.00628	CcSEcCtD
Testolactone—Vomiting—Abiraterone—prostate cancer	0.000226	0.0061	CcSEcCtD
Testolactone—Blood pressure increased—Capecitabine—prostate cancer	0.000226	0.0061	CcSEcCtD
Testolactone—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.000225	0.00608	CcSEcCtD
Testolactone—Feeling abnormal—Cabazitaxel—prostate cancer	0.000225	0.00607	CcSEcCtD
Testolactone—Anorexia—Bicalutamide—prostate cancer	0.000223	0.00603	CcSEcCtD
Testolactone—Vomiting—Estrone—prostate cancer	0.000222	0.006	CcSEcCtD
Testolactone—Malaise—Ethinyl Estradiol—prostate cancer	0.000219	0.00591	CcSEcCtD
Testolactone—CYP19A1—lymph node—prostate cancer	0.000218	0.0555	CbGeAlD
Testolactone—Nausea—Estramustine—prostate cancer	0.000217	0.00586	CcSEcCtD
Testolactone—Paraesthesia—Bicalutamide—prostate cancer	0.00021	0.00568	CcSEcCtD
Testolactone—Nausea—Estrone—prostate cancer	0.000208	0.0056	CcSEcCtD
Testolactone—Vomiting—Nilutamide—prostate cancer	0.000206	0.00557	CcSEcCtD
Testolactone—Vomiting—Flutamide—prostate cancer	0.000205	0.00554	CcSEcCtD
Testolactone—Discomfort—Ethinyl Estradiol—prostate cancer	0.000204	0.00551	CcSEcCtD
Testolactone—Decreased appetite—Bicalutamide—prostate cancer	0.000204	0.0055	CcSEcCtD
Testolactone—Alopecia—Goserelin—prostate cancer	0.000203	0.00547	CcSEcCtD
Testolactone—Alopecia—Conjugated Estrogens—prostate cancer	0.000201	0.00542	CcSEcCtD
Testolactone—Pain—Bicalutamide—prostate cancer	0.0002	0.00541	CcSEcCtD
Testolactone—Erythema—Goserelin—prostate cancer	0.0002	0.00539	CcSEcCtD
Testolactone—Oedema—Ethinyl Estradiol—prostate cancer	0.000198	0.00534	CcSEcCtD
Testolactone—Erythema—Conjugated Estrogens—prostate cancer	0.000198	0.00534	CcSEcCtD
Testolactone—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000194	0.00523	CcSEcCtD
Testolactone—Feeling abnormal—Bicalutamide—prostate cancer	0.000193	0.00521	CcSEcCtD
Testolactone—Nausea—Nilutamide—prostate cancer	0.000193	0.0052	CcSEcCtD
Testolactone—Nausea—Flutamide—prostate cancer	0.000192	0.00518	CcSEcCtD
Testolactone—Ill-defined disorder—Goserelin—prostate cancer	0.000185	0.005	CcSEcCtD
Testolactone—Vomiting—Degarelix—prostate cancer	0.000184	0.00498	CcSEcCtD
Testolactone—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000181	0.00489	CcSEcCtD
Testolactone—Malaise—Goserelin—prostate cancer	0.00018	0.00486	CcSEcCtD
Testolactone—Vomiting—Cabazitaxel—prostate cancer	0.000174	0.00469	CcSEcCtD
Testolactone—Nausea—Degarelix—prostate cancer	0.000172	0.00465	CcSEcCtD
Testolactone—Glossitis—Epirubicin—prostate cancer	0.000171	0.00461	CcSEcCtD
Testolactone—Discomfort—Goserelin—prostate cancer	0.000168	0.00453	CcSEcCtD
Testolactone—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000163	0.0044	CcSEcCtD
Testolactone—Oedema—Goserelin—prostate cancer	0.000163	0.0044	CcSEcCtD
Testolactone—Nausea—Cabazitaxel—prostate cancer	0.000162	0.00438	CcSEcCtD
Testolactone—Oedema—Conjugated Estrogens—prostate cancer	0.000161	0.00436	CcSEcCtD
Testolactone—Alopecia—Estradiol—prostate cancer	0.000161	0.00434	CcSEcCtD
Testolactone—Erythema—Estradiol—prostate cancer	0.000158	0.00427	CcSEcCtD
Testolactone—Glossitis—Doxorubicin—prostate cancer	0.000158	0.00426	CcSEcCtD
Testolactone—Anorexia—Goserelin—prostate cancer	0.000155	0.00419	CcSEcCtD
Testolactone—Anorexia—Conjugated Estrogens—prostate cancer	0.000154	0.00415	CcSEcCtD
Testolactone—Alopecia—Mitoxantrone—prostate cancer	0.00015	0.00404	CcSEcCtD
Testolactone—Vomiting—Bicalutamide—prostate cancer	0.000149	0.00402	CcSEcCtD
Testolactone—Erythema—Mitoxantrone—prostate cancer	0.000148	0.00398	CcSEcCtD
Testolactone—Ill-defined disorder—Estradiol—prostate cancer	0.000147	0.00396	CcSEcCtD
Testolactone—Paraesthesia—Goserelin—prostate cancer	0.000146	0.00395	CcSEcCtD
Testolactone—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000145	0.00391	CcSEcCtD
Testolactone—Malaise—Estradiol—prostate cancer	0.000143	0.00385	CcSEcCtD
Testolactone—Decreased appetite—Goserelin—prostate cancer	0.000142	0.00382	CcSEcCtD
Testolactone—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00014	0.00379	CcSEcCtD
Testolactone—Pain—Goserelin—prostate cancer	0.000139	0.00376	CcSEcCtD
Testolactone—Nausea—Bicalutamide—prostate cancer	0.000139	0.00376	CcSEcCtD
Testolactone—Pain—Conjugated Estrogens—prostate cancer	0.000138	0.00373	CcSEcCtD
Testolactone—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000137	0.00369	CcSEcCtD
Testolactone—Feeling abnormal—Goserelin—prostate cancer	0.000134	0.00362	CcSEcCtD
Testolactone—Discomfort—Estradiol—prostate cancer	0.000133	0.00359	CcSEcCtD
Testolactone—Malaise—Mitoxantrone—prostate cancer	0.000133	0.00359	CcSEcCtD
Testolactone—Oedema—Estradiol—prostate cancer	0.000129	0.00349	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.000127	0.00382	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	0.000126	0.00381	CbGpPWpGaD
Testolactone—Vomiting—Ethinyl Estradiol—prostate cancer	0.000126	0.0034	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP7B1—prostate cancer	0.000125	0.00377	CbGpPWpGaD
Testolactone—Alopecia—Etoposide—prostate cancer	0.000125	0.00336	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000124	0.00376	CbGpPWpGaD
Testolactone—Discomfort—Mitoxantrone—prostate cancer	0.000124	0.00335	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RRAS—prostate cancer	0.000123	0.00373	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP7B1—prostate cancer	0.000123	0.00371	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—SULT1E1—prostate cancer	0.000122	0.00367	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.000121	0.00367	CbGpPWpGaD
Testolactone—Oedema—Mitoxantrone—prostate cancer	0.00012	0.00325	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.00012	0.00363	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—SULT1E1—prostate cancer	0.00012	0.00362	CbGpPWpGaD
Testolactone—CYP19A1—Tryptophan metabolism—CYP1A1—prostate cancer	0.000118	0.00357	CbGpPWpGaD
Testolactone—Nausea—Ethinyl Estradiol—prostate cancer	0.000118	0.00317	CcSEcCtD
Testolactone—Paraesthesia—Estradiol—prostate cancer	0.000116	0.00313	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000116	0.00349	CbGpPWpGaD
Testolactone—Anorexia—Mitoxantrone—prostate cancer	0.000115	0.0031	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000114	0.00345	CbGpPWpGaD
Testolactone—Ill-defined disorder—Etoposide—prostate cancer	0.000114	0.00307	CcSEcCtD
Testolactone—Decreased appetite—Estradiol—prostate cancer	0.000112	0.00303	CcSEcCtD
Testolactone—Malaise—Etoposide—prostate cancer	0.000111	0.00299	CcSEcCtD
Testolactone—Pain—Estradiol—prostate cancer	0.00011	0.00298	CcSEcCtD
Testolactone—Paraesthesia—Mitoxantrone—prostate cancer	0.000108	0.00292	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000108	0.00326	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—CYP3A5—prostate cancer	0.000107	0.00323	CbGpPWpGaD
Testolactone—Feeling abnormal—Estradiol—prostate cancer	0.000106	0.00287	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP3A5—prostate cancer	0.000106	0.00319	CbGpPWpGaD
Testolactone—Decreased appetite—Mitoxantrone—prostate cancer	0.000105	0.00282	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000104	0.00314	CbGpPWpGaD
Testolactone—Vomiting—Goserelin—prostate cancer	0.000104	0.0028	CcSEcCtD
Testolactone—Alopecia—Docetaxel—prostate cancer	0.000104	0.00279	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA3—prostate cancer	0.000103	0.00312	CbGpPWpGaD
Testolactone—Discomfort—Etoposide—prostate cancer	0.000103	0.00279	CcSEcCtD
Testolactone—Pain—Mitoxantrone—prostate cancer	0.000103	0.00278	CcSEcCtD
Testolactone—Vomiting—Conjugated Estrogens—prostate cancer	0.000103	0.00277	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.000102	0.00309	CbGpPWpGaD
Testolactone—Erythema—Docetaxel—prostate cancer	0.000102	0.00275	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GSTA3—prostate cancer	0.000102	0.00308	CbGpPWpGaD
Testolactone—Alopecia—Capecitabine—prostate cancer	0.0001	0.0027	CcSEcCtD
Testolactone—Feeling abnormal—Mitoxantrone—prostate cancer	9.92e-05	0.00268	CcSEcCtD
Testolactone—Erythema—Capecitabine—prostate cancer	9.87e-05	0.00266	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	9.75e-05	0.00294	CbGpPWpGaD
Testolactone—Nausea—Goserelin—prostate cancer	9.68e-05	0.00261	CcSEcCtD
Testolactone—Nausea—Conjugated Estrogens—prostate cancer	9.59e-05	0.00259	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	9.56e-05	0.00289	CbGpPWpGaD
Testolactone—Anorexia—Etoposide—prostate cancer	9.55e-05	0.00258	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—TBXAS1—prostate cancer	9.45e-05	0.00285	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTA4—prostate cancer	9.45e-05	0.00285	CbGpPWpGaD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	9.43e-05	0.00285	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTA4—prostate cancer	9.32e-05	0.00282	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	9.28e-05	0.0028	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTA2—prostate cancer	9.21e-05	0.00278	CbGpPWpGaD
Testolactone—Ill-defined disorder—Capecitabine—prostate cancer	9.16e-05	0.00247	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—SULT1A1—prostate cancer	9.1e-05	0.00275	CbGpPWpGaD
Testolactone—Paraesthesia—Etoposide—prostate cancer	8.99e-05	0.00243	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—SULT1A1—prostate cancer	8.98e-05	0.00271	CbGpPWpGaD
Testolactone—Alopecia—Prednisone—prostate cancer	8.93e-05	0.00241	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AHR—prostate cancer	8.92e-05	0.00269	CbGpPWpGaD
Testolactone—Malaise—Capecitabine—prostate cancer	8.9e-05	0.0024	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—CDKN1B—prostate cancer	8.9e-05	0.00269	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTA1—prostate cancer	8.89e-05	0.00268	CbGpPWpGaD
Testolactone—Erythema—Prednisone—prostate cancer	8.79e-05	0.00237	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—NAT2—prostate cancer	8.79e-05	0.00265	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTO1—prostate cancer	8.79e-05	0.00265	CbGpPWpGaD
Testolactone—CYP19A1—FSH signaling pathway—SRC—prostate cancer	8.71e-05	0.00263	CbGpPWpGaD
Testolactone—Decreased appetite—Etoposide—prostate cancer	8.71e-05	0.00235	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GSTO1—prostate cancer	8.67e-05	0.00262	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—NAT2—prostate cancer	8.67e-05	0.00262	CbGpPWpGaD
Testolactone—Pain—Etoposide—prostate cancer	8.56e-05	0.00231	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2C18—prostate cancer	8.43e-05	0.00254	CbGpPWpGaD
Testolactone—Oedema—Docetaxel—prostate cancer	8.32e-05	0.00225	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2C18—prostate cancer	8.31e-05	0.00251	CbGpPWpGaD
Testolactone—Discomfort—Capecitabine—prostate cancer	8.3e-05	0.00224	CcSEcCtD
Testolactone—Feeling abnormal—Etoposide—prostate cancer	8.25e-05	0.00223	CcSEcCtD
Testolactone—Vomiting—Estradiol—prostate cancer	8.22e-05	0.00222	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—prostate cancer	8.17e-05	0.00247	CbGpPWpGaD
Testolactone—Ill-defined disorder—Prednisone—prostate cancer	8.16e-05	0.0022	CcSEcCtD
Testolactone—Oedema—Capecitabine—prostate cancer	8.06e-05	0.00217	CcSEcCtD
Testolactone—Anorexia—Docetaxel—prostate cancer	7.93e-05	0.00214	CcSEcCtD
Testolactone—Malaise—Prednisone—prostate cancer	7.93e-05	0.00214	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—SULT2A1—prostate cancer	7.83e-05	0.00237	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	7.75e-05	0.00234	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—SULT2A1—prostate cancer	7.73e-05	0.00233	CbGpPWpGaD
Testolactone—Anorexia—Capecitabine—prostate cancer	7.68e-05	0.00207	CcSEcCtD
Testolactone—Nausea—Estradiol—prostate cancer	7.67e-05	0.00207	CcSEcCtD
Testolactone—Vomiting—Mitoxantrone—prostate cancer	7.65e-05	0.00207	CcSEcCtD
Testolactone—Paraesthesia—Docetaxel—prostate cancer	7.47e-05	0.00202	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	7.43e-05	0.00224	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	7.43e-05	0.00224	CbGpPWpGaD
Testolactone—Discomfort—Prednisone—prostate cancer	7.4e-05	0.002	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TGFBR1—prostate cancer	7.39e-05	0.00223	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GPX3—prostate cancer	7.37e-05	0.00223	CbGpPWpGaD
Testolactone—CYP19A1—Tryptophan metabolism—MDM2—prostate cancer	7.29e-05	0.0022	CbGpPWpGaD
Testolactone—Testosterone Propionate—CYP17A1—prostate cancer	7.24e-05	0.0282	CrCbGaD
Testolactone—Paraesthesia—Capecitabine—prostate cancer	7.24e-05	0.00195	CcSEcCtD
Testolactone—Decreased appetite—Docetaxel—prostate cancer	7.23e-05	0.00195	CcSEcCtD
Testolactone—Oedema—Prednisone—prostate cancer	7.18e-05	0.00194	CcSEcCtD
Testolactone—Nausea—Mitoxantrone—prostate cancer	7.15e-05	0.00193	CcSEcCtD
Testolactone—Pain—Docetaxel—prostate cancer	7.12e-05	0.00192	CcSEcCtD
Testolactone—Exemestane—CYP19A1—prostate cancer	7.1e-05	0.0276	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—HPGDS—prostate cancer	7.03e-05	0.00212	CbGpPWpGaD
Testolactone—Decreased appetite—Capecitabine—prostate cancer	7e-05	0.00189	CcSEcCtD
Testolactone—Alopecia—Epirubicin—prostate cancer	6.98e-05	0.00188	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2C19—prostate cancer	6.98e-05	0.00211	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—prostate cancer	6.95e-05	0.0021	CbGpPWpGaD
Testolactone—Testosterone—CYP3A43—prostate cancer	6.92e-05	0.0269	CrCbGaD
Testolactone—Pain—Capecitabine—prostate cancer	6.89e-05	0.00186	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2C19—prostate cancer	6.89e-05	0.00208	CbGpPWpGaD
Testolactone—Erythema—Epirubicin—prostate cancer	6.88e-05	0.00186	CcSEcCtD
Testolactone—Feeling abnormal—Docetaxel—prostate cancer	6.86e-05	0.00185	CcSEcCtD
Testolactone—Anorexia—Prednisone—prostate cancer	6.84e-05	0.00185	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTT1—prostate cancer	6.81e-05	0.00206	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AURKA—prostate cancer	6.76e-05	0.00204	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—CYP2A6—prostate cancer	6.74e-05	0.00203	CbGpPWpGaD
Testolactone—Dexamethasone—CYP3A43—prostate cancer	6.7e-05	0.026	CrCbGaD
Testolactone—Feeling abnormal—Capecitabine—prostate cancer	6.64e-05	0.00179	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—prostate cancer	6.62e-05	0.002	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	6.5e-05	0.00196	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—AKR1C3—prostate cancer	6.46e-05	0.00195	CbGpPWpGaD
Testolactone—Alopecia—Doxorubicin—prostate cancer	6.46e-05	0.00174	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP17A1—prostate cancer	6.45e-05	0.00195	CbGpPWpGaD
Testolactone—Paraesthesia—Prednisone—prostate cancer	6.44e-05	0.00174	CcSEcCtD
Testolactone—Ill-defined disorder—Epirubicin—prostate cancer	6.38e-05	0.00172	CcSEcCtD
Testolactone—Vomiting—Etoposide—prostate cancer	6.37e-05	0.00172	CcSEcCtD
Testolactone—Erythema—Doxorubicin—prostate cancer	6.36e-05	0.00172	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP17A1—prostate cancer	6.36e-05	0.00192	CbGpPWpGaD
Testolactone—Decreased appetite—Prednisone—prostate cancer	6.24e-05	0.00168	CcSEcCtD
Testolactone—Malaise—Epirubicin—prostate cancer	6.2e-05	0.00167	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	6.16e-05	0.00186	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	6.16e-05	0.00186	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	6.16e-05	0.00186	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—NCOA2—prostate cancer	6.15e-05	0.00186	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—prostate cancer	6.05e-05	0.00183	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP9—prostate cancer	5.99e-05	0.00181	CbGpPWpGaD
Testolactone—Nausea—Etoposide—prostate cancer	5.95e-05	0.00161	CcSEcCtD
Testolactone—Feeling abnormal—Prednisone—prostate cancer	5.91e-05	0.0016	CcSEcCtD
Testolactone—Ill-defined disorder—Doxorubicin—prostate cancer	5.9e-05	0.00159	CcSEcCtD
Testolactone—Testosterone Propionate—COMT—prostate cancer	5.9e-05	0.023	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	5.88e-05	0.00177	CbGpPWpGaD
Testolactone—Discomfort—Epirubicin—prostate cancer	5.79e-05	0.00156	CcSEcCtD
Testolactone—Malaise—Doxorubicin—prostate cancer	5.74e-05	0.00155	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2E1—prostate cancer	5.73e-05	0.00173	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—prostate cancer	5.67e-05	0.00171	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2E1—prostate cancer	5.65e-05	0.00171	CbGpPWpGaD
Testolactone—Oedema—Epirubicin—prostate cancer	5.61e-05	0.00151	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP3A4—prostate cancer	5.52e-05	0.00167	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AR—prostate cancer	5.51e-05	0.00166	CbGpPWpGaD
Testolactone—Prednicarbate—NR3C1—prostate cancer	5.49e-05	0.0214	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP3A4—prostate cancer	5.45e-05	0.00164	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—CYP1B1—prostate cancer	5.43e-05	0.00164	CbGpPWpGaD
Testolactone—CYP19A1—FSH signaling pathway—AKT1—prostate cancer	5.41e-05	0.00163	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP1B1—prostate cancer	5.36e-05	0.00162	CbGpPWpGaD
Testolactone—Discomfort—Doxorubicin—prostate cancer	5.35e-05	0.00144	CcSEcCtD
Testolactone—Anorexia—Epirubicin—prostate cancer	5.35e-05	0.00144	CcSEcCtD
Testolactone—Dexamethasone—ANXA1—prostate cancer	5.29e-05	0.0206	CrCbGaD
Testolactone—Vomiting—Docetaxel—prostate cancer	5.29e-05	0.00143	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GGT1—prostate cancer	5.26e-05	0.00159	CbGpPWpGaD
Testolactone—Drospirenone—AR—prostate cancer	5.24e-05	0.0204	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—prostate cancer	5.24e-05	0.00158	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	5.24e-05	0.00158	CbGpPWpGaD
Testolactone—Desonide—NR3C1—prostate cancer	5.2e-05	0.0202	CrCbGaD
Testolactone—Oedema—Doxorubicin—prostate cancer	5.19e-05	0.0014	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—NCOA1—prostate cancer	5.18e-05	0.00156	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—prostate cancer	5.12e-05	0.00155	CbGpPWpGaD
Testolactone—Vomiting—Capecitabine—prostate cancer	5.12e-05	0.00138	CcSEcCtD
Testolactone—Desoximetasone—NR3C1—prostate cancer	5.07e-05	0.0197	CrCbGaD
Testolactone—Paraesthesia—Epirubicin—prostate cancer	5.04e-05	0.00136	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—prostate cancer	5.02e-05	0.00152	CbGpPWpGaD
Testolactone—Loteprednol—NR3C1—prostate cancer	5.01e-05	0.0195	CrCbGaD
Testolactone—Anorexia—Doxorubicin—prostate cancer	4.95e-05	0.00134	CcSEcCtD
Testolactone—Nausea—Docetaxel—prostate cancer	4.94e-05	0.00133	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—RXRA—prostate cancer	4.93e-05	0.00149	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	4.92e-05	0.00149	CbGpPWpGaD
Testolactone—Decreased appetite—Epirubicin—prostate cancer	4.88e-05	0.00132	CcSEcCtD
Testolactone—Pain—Epirubicin—prostate cancer	4.8e-05	0.0013	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	4.79e-05	0.00145	CbGpPWpGaD
Testolactone—Nausea—Capecitabine—prostate cancer	4.79e-05	0.00129	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—COMT—prostate cancer	4.75e-05	0.00143	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTP1—prostate cancer	4.72e-05	0.00143	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BAX—prostate cancer	4.69e-05	0.00142	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—COMT—prostate cancer	4.68e-05	0.00141	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	4.67e-05	0.00141	CbGpPWpGaD
Testolactone—Paraesthesia—Doxorubicin—prostate cancer	4.66e-05	0.00126	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GSTP1—prostate cancer	4.66e-05	0.00141	CbGpPWpGaD
Testolactone—Fluoxymesterone—SHBG—prostate cancer	4.65e-05	0.0181	CrCbGaD
Testolactone—Feeling abnormal—Epirubicin—prostate cancer	4.63e-05	0.00125	CcSEcCtD
Testolactone—Vomiting—Prednisone—prostate cancer	4.56e-05	0.00123	CcSEcCtD
Testolactone—Decreased appetite—Doxorubicin—prostate cancer	4.52e-05	0.00122	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	4.45e-05	0.00134	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	4.45e-05	0.00134	CbGpPWpGaD
Testolactone—Danazol—SHBG—prostate cancer	4.44e-05	0.0173	CrCbGaD
Testolactone—Pain—Doxorubicin—prostate cancer	4.44e-05	0.0012	CcSEcCtD
Testolactone—Testosterone Propionate—AR—prostate cancer	4.4e-05	0.0171	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—GSTM1—prostate cancer	4.34e-05	0.00131	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTM1—prostate cancer	4.28e-05	0.00129	CbGpPWpGaD
Testolactone—Feeling abnormal—Doxorubicin—prostate cancer	4.28e-05	0.00116	CcSEcCtD
Testolactone—Nausea—Prednisone—prostate cancer	4.26e-05	0.00115	CcSEcCtD
Testolactone—Spironolactone—SHBG—prostate cancer	4.26e-05	0.0166	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—CYP1A1—prostate cancer	4.12e-05	0.00124	CbGpPWpGaD
Testolactone—Fluoxymesterone—AR—prostate cancer	4.08e-05	0.0159	CrCbGaD
Testolactone—CYP19A1—Metabolism—HAO1—prostate cancer	4.06e-05	0.00123	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP1A1—prostate cancer	4.06e-05	0.00123	CbGpPWpGaD
Testolactone—Budesonide—NR3C1—prostate cancer	3.99e-05	0.0155	CrCbGaD
Testolactone—Estrone—ESR2—prostate cancer	3.93e-05	0.0153	CrCbGaD
Testolactone—Danazol—AR—prostate cancer	3.9e-05	0.0152	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ATM—prostate cancer	3.82e-05	0.00115	CbGpPWpGaD
Testolactone—Mometasone—NR3C1—prostate cancer	3.8e-05	0.0148	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	3.79e-05	0.00114	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—prostate cancer	3.78e-05	0.00114	CbGpPWpGaD
Testolactone—Methyltestosterone—SHBG—prostate cancer	3.76e-05	0.0146	CrCbGaD
Testolactone—Rimexolone—NR3C1—prostate cancer	3.75e-05	0.0146	CrCbGaD
Testolactone—Spironolactone—AR—prostate cancer	3.73e-05	0.0145	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BAD—prostate cancer	3.69e-05	0.00112	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	3.63e-05	0.0011	CbGpPWpGaD
Testolactone—Estrone—SHBG—prostate cancer	3.58e-05	0.0139	CrCbGaD
Testolactone—Estrone—CYP1B1—prostate cancer	3.58e-05	0.0139	CrCbGaD
Testolactone—Vomiting—Epirubicin—prostate cancer	3.57e-05	0.000963	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—IRS1—prostate cancer	3.54e-05	0.00107	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	3.49e-05	0.00106	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	3.37e-05	0.00102	CbGpPWpGaD
Testolactone—Exemestane—CYP3A4—prostate cancer	3.34e-05	0.013	CrCbGaD
Testolactone—Nausea—Epirubicin—prostate cancer	3.33e-05	0.0009	CcSEcCtD
Testolactone—Progesterone—CYP17A1—prostate cancer	3.32e-05	0.0129	CrCbGaD
Testolactone—CYP19A1—Metabolism—CSAD—prostate cancer	3.31e-05	0.001	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CBR1—prostate cancer	3.31e-05	0.001	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GRHL1—prostate cancer	3.31e-05	0.001	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ADI1—prostate cancer	3.31e-05	0.001	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TST—prostate cancer	3.31e-05	0.001	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PSAT1—prostate cancer	3.31e-05	0.001	CbGpPWpGaD
Testolactone—Vomiting—Doxorubicin—prostate cancer	3.3e-05	0.000891	CcSEcCtD
Testolactone—Methyltestosterone—AR—prostate cancer	3.29e-05	0.0128	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—prostate cancer	3.29e-05	0.000994	CbGpPWpGaD
Testolactone—Danazol—CYP19A1—prostate cancer	3.26e-05	0.0127	CrCbGaD
Testolactone—Ciclesonide—NR3C1—prostate cancer	3.25e-05	0.0126	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	3.24e-05	0.000977	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	3.17e-05	0.000958	CbGpPWpGaD
Testolactone—Progesterone—SLC22A3—prostate cancer	3.17e-05	0.0123	CrCbGaD
Testolactone—Fluoxymesterone—ESR1—prostate cancer	3.14e-05	0.0122	CrCbGaD
Testolactone—Methylprednisolone—NR3C1—prostate cancer	3.12e-05	0.0121	CrCbGaD
Testolactone—Nausea—Doxorubicin—prostate cancer	3.09e-05	0.000833	CcSEcCtD
Testolactone—CYP19A1—Metabolism—CKMT2—prostate cancer	3.08e-05	0.000929	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UGT2B17—prostate cancer	3.08e-05	0.000929	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UGT2B15—prostate cancer	3.08e-05	0.000929	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GRHPR—prostate cancer	3.08e-05	0.000929	CbGpPWpGaD
Testolactone—Dexamethasone—CYP17A1—prostate cancer	3.04e-05	0.0118	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	3.01e-05	0.000908	CbGpPWpGaD
Testolactone—Danazol—ESR1—prostate cancer	3e-05	0.0117	CrCbGaD
Testolactone—Testosterone—SLC22A3—prostate cancer	3e-05	0.0117	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—MED12—prostate cancer	2.96e-05	0.000894	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SULT2B1—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—RFK—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NAGLU—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTM3—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AOX1—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PGAM2—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MBTPS1—prostate cancer	2.89e-05	0.000874	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—prostate cancer	2.86e-05	0.000863	CbGpPWpGaD
Testolactone—Estrone—CYP3A5—prostate cancer	2.85e-05	0.0111	CrCbGaD
Testolactone—Prednisolone—CYP2A6—prostate cancer	2.85e-05	0.0111	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	2.83e-05	0.000854	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—prostate cancer	2.82e-05	0.000851	CbGpPWpGaD
Testolactone—Fluoxymesterone—NR3C1—prostate cancer	2.77e-05	0.0108	CrCbGaD
Testolactone—Methyltestosterone—CYP19A1—prostate cancer	2.76e-05	0.0107	CrCbGaD
Testolactone—CYP19A1—Metabolism—DEGS1—prostate cancer	2.74e-05	0.000828	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SRD5A2—prostate cancer	2.74e-05	0.000828	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NAT1—prostate cancer	2.74e-05	0.000828	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP3A43—prostate cancer	2.74e-05	0.000828	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AMACR—prostate cancer	2.74e-05	0.000828	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	2.7e-05	0.000815	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	2.68e-05	0.00081	CbGpPWpGaD
Testolactone—Betamethasone—CYP19A1—prostate cancer	2.66e-05	0.0103	CrCbGaD
Testolactone—Triamcinolone—NR3C1—prostate cancer	2.63e-05	0.0102	CrCbGaD
Testolactone—CYP19A1—Metabolism—HSD17B1—prostate cancer	2.62e-05	0.00079	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	2.62e-05	0.00079	CbGpPWpGaD
Testolactone—Spironolactone—NR3C1—prostate cancer	2.53e-05	0.00985	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—prostate cancer	2.52e-05	0.000761	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	2.52e-05	0.00076	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	2.5e-05	0.000756	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	2.48e-05	0.000748	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—prostate cancer	2.45e-05	0.000741	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	2.43e-05	0.000734	CbGpPWpGaD
Testolactone—Estrone—ESR1—prostate cancer	2.42e-05	0.00941	CrCbGaD
Testolactone—Prednisone—NR3C1—prostate cancer	2.39e-05	0.00928	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—prostate cancer	2.37e-05	0.000715	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.36e-05	0.000713	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HPGD—prostate cancer	2.33e-05	0.000704	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—B4GALT4—prostate cancer	2.33e-05	0.000704	CbGpPWpGaD
Testolactone—Budesonide—CYP3A4—prostate cancer	2.31e-05	0.00899	CrCbGaD
Testolactone—Progesterone—SHBG—prostate cancer	2.3e-05	0.00896	CrCbGaD
Testolactone—Progesterone—CYP1B1—prostate cancer	2.3e-05	0.00896	CrCbGaD
Testolactone—Progesterone—SLC22A1—prostate cancer	2.27e-05	0.00884	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EP300—prostate cancer	2.26e-05	0.000682	CbGpPWpGaD
Testolactone—Prednisolone—NR3C1—prostate cancer	2.2e-05	0.00855	CrCbGaD
Testolactone—CYP19A1—Metabolism—TNFRSF21—prostate cancer	2.19e-05	0.000662	CbGpPWpGaD
Testolactone—Testosterone—SHBG—prostate cancer	2.18e-05	0.00847	CrCbGaD
Testolactone—Testosterone—CYP1B1—prostate cancer	2.18e-05	0.00847	CrCbGaD
Testolactone—Prednisone—CYP2C19—prostate cancer	2.17e-05	0.00846	CrCbGaD
Testolactone—Betamethasone—NR3C1—prostate cancer	2.15e-05	0.00838	CrCbGaD
Testolactone—Testosterone—SLC22A1—prostate cancer	2.15e-05	0.00836	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	2.14e-05	0.000646	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTAP—prostate cancer	2.13e-05	0.000644	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP7B1—prostate cancer	2.13e-05	0.000644	CbGpPWpGaD
Testolactone—Dexamethasone—CYP1B1—prostate cancer	2.11e-05	0.0082	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.09e-05	0.00063	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SRD5A1—prostate cancer	2.08e-05	0.000628	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SULT1E1—prostate cancer	2.08e-05	0.000628	CbGpPWpGaD
Testolactone—Progesterone—AR—prostate cancer	2.02e-05	0.00786	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.02e-05	0.00061	CbGpPWpGaD
Testolactone—Drospirenone—PTGS2—prostate cancer	2.02e-05	0.00785	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.99e-05	0.000601	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ACSL4—prostate cancer	1.98e-05	0.000599	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSD17B3—prostate cancer	1.98e-05	0.000599	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MYC—prostate cancer	1.97e-05	0.000594	CbGpPWpGaD
Testolactone—Estrone—CYP2E1—prostate cancer	1.96e-05	0.00763	CrCbGaD
Testolactone—Estrone—CYP1A1—prostate cancer	1.93e-05	0.00752	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	1.93e-05	0.000581	CbGpPWpGaD
Testolactone—Testosterone—AR—prostate cancer	1.91e-05	0.00743	CrCbGaD
Testolactone—CYP19A1—Metabolism—ARG2—prostate cancer	1.9e-05	0.000574	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UMPS—prostate cancer	1.9e-05	0.000574	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PHGDH—prostate cancer	1.9e-05	0.000574	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.89e-05	0.000571	CbGpPWpGaD
Testolactone—Ciclesonide—CYP3A4—prostate cancer	1.89e-05	0.00733	CrCbGaD
Testolactone—CYP19A1—Metabolism—LDHB—prostate cancer	1.86e-05	0.000563	CbGpPWpGaD
Testolactone—Progesterone—CYP3A5—prostate cancer	1.84e-05	0.00714	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP3A5—prostate cancer	1.83e-05	0.000553	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	1.82e-05	0.000549	CbGpPWpGaD
Testolactone—Methylprednisolone—CYP3A4—prostate cancer	1.81e-05	0.00703	CrCbGaD
Testolactone—Progesterone—CYP2A6—prostate cancer	1.78e-05	0.00691	CrCbGaD
Testolactone—CYP19A1—Metabolism—UCP3—prostate cancer	1.77e-05	0.000534	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TCN2—prostate cancer	1.77e-05	0.000534	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PDHA1—prostate cancer	1.77e-05	0.000534	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA3—prostate cancer	1.77e-05	0.000534	CbGpPWpGaD
Testolactone—Testosterone—CYP3A5—prostate cancer	1.73e-05	0.00675	CrCbGaD
Testolactone—CYP19A1—Metabolism—HSD3B1—prostate cancer	1.69e-05	0.000509	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC22A3—prostate cancer	1.69e-05	0.000509	CbGpPWpGaD
Testolactone—Dexamethasone—CYP3A5—prostate cancer	1.68e-05	0.00653	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.64e-05	0.000494	CbGpPWpGaD
Testolactone—Dexamethasone—CYP2A6—prostate cancer	1.62e-05	0.00632	CrCbGaD
Testolactone—CYP19A1—Metabolism—GSTA4—prostate cancer	1.62e-05	0.000488	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TBXAS1—prostate cancer	1.62e-05	0.000488	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TP53—prostate cancer	1.62e-05	0.000488	CbGpPWpGaD
Testolactone—Testosterone—CYP19A1—prostate cancer	1.6e-05	0.00622	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.58e-05	0.000477	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA2—prostate cancer	1.58e-05	0.000476	CbGpPWpGaD
Testolactone—Progesterone—ESR1—prostate cancer	1.56e-05	0.00605	CrCbGaD
Testolactone—CYP19A1—Metabolism—SULT1A1—prostate cancer	1.56e-05	0.00047	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ABCG5—prostate cancer	1.56e-05	0.00047	CbGpPWpGaD
Testolactone—Dexamethasone—CYP19A1—prostate cancer	1.55e-05	0.00602	CrCbGaD
Testolactone—Danazol—CYP3A4—prostate cancer	1.53e-05	0.00596	CrCbGaD
Testolactone—Triamcinolone—CYP3A4—prostate cancer	1.52e-05	0.00593	CrCbGaD
Testolactone—CYP19A1—Metabolism—GSTA1—prostate cancer	1.52e-05	0.000459	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NAT2—prostate cancer	1.5e-05	0.000454	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSD3B2—prostate cancer	1.5e-05	0.000454	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTO1—prostate cancer	1.5e-05	0.000454	CbGpPWpGaD
Testolactone—Triamcinolone—PTGS2—prostate cancer	1.49e-05	0.00581	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.45e-05	0.000436	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PLCB2—prostate cancer	1.44e-05	0.000435	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—LRP2—prostate cancer	1.44e-05	0.000435	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP2C18—prostate cancer	1.44e-05	0.000435	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—P4HB—prostate cancer	1.41e-05	0.000427	CbGpPWpGaD
Testolactone—Prednisone—CYP3A4—prostate cancer	1.38e-05	0.00538	CrCbGaD
Testolactone—CYP19A1—Metabolism—SLC22A1—prostate cancer	1.37e-05	0.000415	CbGpPWpGaD
Testolactone—Progesterone—NR3C1—prostate cancer	1.37e-05	0.00533	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	1.36e-05	0.000412	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.36e-05	0.00041	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SULT2A1—prostate cancer	1.34e-05	0.000404	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MED12—prostate cancer	1.32e-05	0.000398	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GNG5—prostate cancer	1.31e-05	0.000395	CbGpPWpGaD
Testolactone—Methyltestosterone—CYP3A4—prostate cancer	1.29e-05	0.00503	CrCbGaD
Testolactone—Prednisolone—CYP3A4—prostate cancer	1.27e-05	0.00496	CrCbGaD
Testolactone—CYP19A1—Metabolism—NCOA3—prostate cancer	1.26e-05	0.00038	CbGpPWpGaD
Testolactone—Dexamethasone—NR3C1—prostate cancer	1.25e-05	0.00487	CrCbGaD
Testolactone—Progesterone—CYP2C19—prostate cancer	1.25e-05	0.00486	CrCbGaD
Testolactone—Betamethasone—CYP3A4—prostate cancer	1.25e-05	0.00486	CrCbGaD
Testolactone—Progesterone—CYP1A1—prostate cancer	1.24e-05	0.00484	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.24e-05	0.000374	CbGpPWpGaD
Testolactone—Estrone—CYP3A4—prostate cancer	1.23e-05	0.0048	CrCbGaD
Testolactone—Betamethasone—PTGS2—prostate cancer	1.22e-05	0.00476	CrCbGaD
Testolactone—CYP19A1—Metabolism—HPGDS—prostate cancer	1.2e-05	0.000363	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP2C19—prostate cancer	1.19e-05	0.000361	CbGpPWpGaD
Testolactone—Testosterone—CYP2C19—prostate cancer	1.18e-05	0.00459	CrCbGaD
Testolactone—Testosterone—CYP1A1—prostate cancer	1.18e-05	0.00457	CrCbGaD
Testolactone—CYP19A1—Metabolism—GSTT1—prostate cancer	1.17e-05	0.000352	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ACHE—prostate cancer	1.17e-05	0.000352	CbGpPWpGaD
Testolactone—Dexamethasone—CYP2E1—prostate cancer	1.15e-05	0.00449	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP2A6—prostate cancer	1.15e-05	0.000348	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.15e-05	0.000346	CbGpPWpGaD
Testolactone—Dexamethasone—CYP2C19—prostate cancer	1.14e-05	0.00444	CrCbGaD
Testolactone—Dexamethasone—CYP1A1—prostate cancer	1.14e-05	0.00443	CrCbGaD
Testolactone—CYP19A1—Metabolism—AKR1C3—prostate cancer	1.12e-05	0.000338	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PRKACB—prostate cancer	1.11e-05	0.000337	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP17A1—prostate cancer	1.1e-05	0.000333	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.09e-05	0.000329	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOA2—prostate cancer	1.05e-05	0.000317	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC5A5—prostate cancer	1e-05	0.000303	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP2E1—prostate cancer	9.8e-06	0.000296	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NQO1—prostate cancer	9.69e-06	0.000292	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TH—prostate cancer	9.55e-06	0.000288	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	9.48e-06	0.000286	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP3A4—prostate cancer	9.45e-06	0.000285	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	9.4e-06	0.000284	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP1B1—prostate cancer	9.29e-06	0.00028	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GGT1—prostate cancer	8.99e-06	0.000272	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOA1—prostate cancer	8.86e-06	0.000267	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—RXRA—prostate cancer	8.43e-06	0.000254	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.2e-06	0.000247	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—COMT—prostate cancer	8.12e-06	0.000245	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTP1—prostate cancer	8.08e-06	0.000244	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ITPR1—prostate cancer	7.95e-06	0.00024	CbGpPWpGaD
Testolactone—Progesterone—CYP3A4—prostate cancer	7.94e-06	0.00309	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.82e-06	0.000236	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TYMS—prostate cancer	7.51e-06	0.000227	CbGpPWpGaD
Testolactone—Testosterone—CYP3A4—prostate cancer	7.51e-06	0.00292	CrCbGaD
Testolactone—CYP19A1—Metabolism—GSTM1—prostate cancer	7.42e-06	0.000224	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—LPL—prostate cancer	7.29e-06	0.00022	CbGpPWpGaD
Testolactone—Dexamethasone—CYP3A4—prostate cancer	7.26e-06	0.00283	CrCbGaD
Testolactone—Dexamethasone—PTGS2—prostate cancer	7.11e-06	0.00277	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP1A1—prostate cancer	7.04e-06	0.000212	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ERCC2—prostate cancer	6.98e-06	0.000211	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTHFR—prostate cancer	6.56e-06	0.000198	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPARA—prostate cancer	6.44e-06	0.000194	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CAV1—prostate cancer	6.05e-06	0.000183	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.78e-06	0.000175	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CG—prostate cancer	5.51e-06	0.000166	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—INS—prostate cancer	5.22e-06	0.000158	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CREBBP—prostate cancer	5.11e-06	0.000154	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CD—prostate cancer	4.85e-06	0.000146	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NOS3—prostate cancer	4.58e-06	0.000138	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CB—prostate cancer	4.22e-06	0.000128	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTGS2—prostate cancer	4.18e-06	0.000126	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTEN—prostate cancer	3.65e-06	0.00011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—EP300—prostate cancer	3.48e-06	0.000105	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CA—prostate cancer	2.57e-06	7.77e-05	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKT1—prostate cancer	2.1e-06	6.35e-05	CbGpPWpGaD
